ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学内発行雑誌
  2. The Showa University journal of medical sciences
  3. Vol.32(2020)
  4. No.4

Efficacy of Mepolizumab for Long-term Treatment in Patients with Severe Asthma

https://showa.repo.nii.ac.jp/records/3655
https://showa.repo.nii.ac.jp/records/3655
789544a1-c81a-4ae7-8fa9-6a1e2a71fe38
名前 / ファイル ライセンス アクション
S32_247.pdf S32_247.pdf (434.0 kB)
Item type 学内発行雑誌 / Departmental Bulletin Paper(1)
公開日 2021-03-18
タイトル
タイトル Efficacy of Mepolizumab for Long-term Treatment in Patients with Severe Asthma
言語
言語 eng
資源タイプ
資源タイプ departmental bulletin paper
著者 MIYATA, Yoshito

× MIYATA, Yoshito

MIYATA, Yoshito

Search repository
OHTA, Shin

× OHTA, Shin

OHTA, Shin

Search repository
TANAKA, Akihiko

× TANAKA, Akihiko

TANAKA, Akihiko

Search repository
AKIMOTO, Kaho

× AKIMOTO, Kaho

AKIMOTO, Kaho

Search repository
SATO, Hiroki

× SATO, Hiroki

SATO, Hiroki

Search repository
UNO, Tomoki

× UNO, Tomoki

UNO, Tomoki

Search repository
SATO, Haruna

× SATO, Haruna

SATO, Haruna

Search repository
UCHIDA, Yoshitaka

× UCHIDA, Yoshitaka

UCHIDA, Yoshitaka

Search repository
JINNO, Megumi

× JINNO, Megumi

JINNO, Megumi

Search repository
HIRAI, Kuniaki

× HIRAI, Kuniaki

HIRAI, Kuniaki

Search repository
INOUE, Hideki

× INOUE, Hideki

INOUE, Hideki

Search repository
HONMA, Tetsuya

× HONMA, Tetsuya

HONMA, Tetsuya

Search repository
YAMAMOTO, Mayumi

× YAMAMOTO, Mayumi

YAMAMOTO, Mayumi

Search repository
SUZUKI, Shintaro

× SUZUKI, Shintaro

SUZUKI, Shintaro

Search repository
SAGARA, Hironori

× SAGARA, Hironori

SAGARA, Hironori

Search repository
書誌情報 The Showa University journal of medical sciences

巻 32, 号 4, p. 247-256, 発行日 2021-01
抄録
内容記述タイプ Abstract
内容記述 Mepolizumab is a monoclonal antibody against interleukin-5 used for the treatment of severe asthma. The effect of long-term mepolizumab administration and its persistence in clinical practice is poorly understood. Thus, this study aimed to investigate the effect of long-term administration of mepolizumab in patients with severe asthma. Mepolizumab was administered to 20 patients with severe asthma. We then prospectively followed the patients for 104 weeks to investigate the efficacy of long-term mepolizumab administration in clinical practice. Eleven patients were evaluated for 104 weeks. Mepolizumab administration reduced asthma exacerbations in a year from 52 to 104 weeks and improved asthma control in every period as assessed by questionnaires. Also, blood eosinophil counts decreased at every point, and blood basophil counts decreased at 104 weeks. We compared various parameters among the 11 patients who continued administration for more than 104 weeks and 7 patients who discontinued treatment due to ineffectiveness. Significant differences were observed in disease duration, maximum expiratory flow at 50%, and blood basophil count. Long-term mepolizumab administration improved asthma symptoms in patients with severe asthma and reduced the frequency of exacerbations.
DOI
関連識別子 10.15369/sujms.32.247
出版者
出版者 Showa University Society
ISSN
収録物識別子 2185-0968
著者版フラグ
出版タイプ VoR
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 11:57:36.997626
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3